Eppen_TracePCR_Dec24
  Editorial
 THE INDIAN PHARMACOPOEIA 2026   
 Wednesday, February 18, 2026 
 On January 2, 2026, the Indian Pharmacopoeia Commission (IPC) released the Indian Pharmacopoeia 2026 (IP-2026) which is the 10th edition of India’s official book of drug standards. IP-2026 contains a total 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Bioemtech, NorthStar ink supply agreement for Actinium-225 to support preclinical radiopharmaceutical research
17:50  [IST]Cambridge Cognition partners with brain-health startup Ivory to scale early cognitive screening with CANTAB Pathway in India
17:45  [IST]Wadhwani AI and AIIMS’ MadhuNetrAI wins top recognition at India AI Impact Summit 2026
17:40  [IST]Medikabazaar after recent turnaround to raise $50 million to fuel growth
17:30  [IST]NIO Super Specialty Hospital doctors receive national recognition for pioneering research in advanced eye cancer imaging
17:00  [IST]US FDA approves Harmony Biosciences’ pitolisant for the treatment of cataplexy in paediatric patients
more news >>
TOP NEWS
08:00  [IST]CDSCO directs manufacturers of doxycycline & carbimazole to add new side effects in package information
08:00  [IST]AIOCD warns of grave public health threat as AI-generated fake prescriptions fuel illegal online drug sales
08:00  [IST]CDSCO soon to streamline online application for WHO-GMP CoPP to boost Ease of Doing Business
08:00  [IST]PCI asks pharmacy institutions to conduct Pharma Anveshan Programme on March 6
08:00  [IST]KPRDO pushes Karnataka govt to prioritize pharma trade welfare in its upcoming state budget
08:00  [IST]MDC to discuss requests for separate pricing for cementless knee implants in next meeting
more news >>
YESTERDAY'S NEWS
18:00  [IST]Newron secures up to EUR 38 million to advance its ENIGMA-TRS pivotal phase III programme
17:45  [IST]Kotak Alts invests Rs. 400 million in Zeroharm Sciences
17:10  [IST]IP Alliance to host the 11th Global Pharmaceutical Quality Summit between Feb 23 and 24, 2026, in Mumbai
17:00  [IST]Sygnature Discovery announces a strategic brand relaunch to cement its status as a global drug discovery partner
16:00  [IST]Disc Medicine receives CRL from US FDA for its NDA of bitopertin to treat erythropoietic protoporphyria
15:00  [IST]UK MHRA launches a consultation on indefinite recognition of CE-marked medical devices
more news >>
INTERVIEW  
Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram